Johnson & Johnson (NYSE:JNJ) and Apple (NSDQ:AAPL) announced today that they’ve opened enrollment for the Heartline Study, which will look at the ability of Apple Watch heart health features to reduce stroke risks. The Janssen Pharmaceutical Cos. of Johnson & Johnson, in collaboration with Apple, are looking for U.S. residents over 65 who have an iPhone 6s […]
Johnson & Johnson
J&J’s Ethicon mostly fends off Intuitive Surgical’s robotic surgery patent challenge
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon has kept most of a surgical robotics tool patent intact after a Patent Trial and Appeal Board decision on a challenge from rival Intuitive Surgical (NSDQ:ISRG). The board’s decision, dated Feb. 18, involved an Ethicon patent for a “Shiftable Drive Interface for Robotically-Controlled Surgical Tool,” issued in 2013. Out of […]
DePuy Synthes and Orthofix settle customer-poaching lawsuit
Johnson & Johnson (NYSE:JNJ) unit DePuy Synthes has settled its lawsuit over alleged customer-poaching against Orthofix (NSDQ:OFIX) and a pair of former DePuy sales reps for an undisclosed amount. The confidential settlement comes nearly 11 months after DePuy filed suit in the U.S. District Court for Eastern Texas, alleging that its rival lured the reps and two […]
BREAKING: J&J ordered to pay $344m in California pelvic mesh case
A California judge ruled today that Johnson & Johnson and its Ethicon subsidiary must pay $344 million in penalties in a case claiming false and deceptive marketing of its pelvic mesh products for women. The California Department of Justice said it sued Johnson & Johnson in May 2016 after a years-long multistate investigation revealed the […]
Johnson & Johnson planning a robotic surgery reveal in May
Johnson & Johnson (NYSE:JNJ) appears to be preparing a preview of its robotic and digital surgery plans at a Medical Device Business Review Day that the company is planning May 13 in New York City. “We think it will provide a very clear, transparent kind of tangible evidence of not only the machines but also the […]
Johnson & Johnson misses the mark on Q4 revenue
Johnson & Johnson (NYSE:JNJ) today reported fourth-quarter earnings that beat the consensus forecast on Wall Street, but its sales numbers were slightly off amid declining medical device revenue. The New Brunswick, N.J.–based pharmaceutical, medical device and consumer products giant reported profits of $4.0 billion, or $1.50 per share, on sales of $20.7 billion for the three […]
Court tosses J&J’s appeal in $20 million pelvic mesh case
This article has been updated with a comment from Ethicon. An Indiana federal appeals court yesterday upheld a $20 million jury award in a pelvic mesh case against Johnson & Johnson’s (NYSE:JNJ) Ethicon unit. Despite the “flurry of arguments” in its appeal, the company failed to convince the three-judge panel that it should overturn the […]
J&J’s Ethicon defeats all but 4 claims in Kentucky pelvic mesh case
A federal judge in Kentucky has dismissed all but four claims in a pelvic mesh lawsuit against Johnson & Johnson’s (NYSE:JNJ) Ethicon division. Jensesta Cutter had Ethicon’s Prolift pelvic mesh implanted in 2006 and complained to her doctor that year of pelvic pain, soreness and burning, constipation and urine leakage, according to the complaint. In […]
The 10 greatest medtech advances of the 2010s
From disposable endoscopes to TAVR to robotic surgery, there’s a whole host of medtech advances widely available now that weren’t around much 10 years ago. “In terms of technological advances, I would put this past decade as one of the most important for medical technology. From connected devices and robotics, to advances in material sciences […]
10 medical device industry stories you need to know
From leadership changes to tax repeal to robots — lots of robots — this was a busy year for the medical device industry. Here are 10 stories in the medtech space that especially caught the eye of MassDevice and Medical Design & Outsourcing editors and readers in 2019. Next>>
